← All Cardlytics, INC filings

Cardlytics, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
CDLX
Cardlytics, INC
SCHEDULE: Sosin Entities Adjust Cardlytics Stake to 9.8%
CAS Investment Partners and affiliated entities have updated their beneficial ownership in Cardlytics, Inc. to 9.8% through recent transactions and distributions.
NASDAQ
CDLX
Cardlytics, INC
SCHEDULE 13D/A: CAS Investment Partners Updates Cardlytics Stake to 11.0% Following Share Distribution and Note Sale
CAS Investment Partners, LLC and its affiliates have filed an amended Schedule 13D, confirming their aggregate beneficial ownership of 11.0% in Cardlytics, Inc. common stock, following recent share distributions and a sale of convertible notes.